Skip to main content
. 2022 Apr 28;2022:6304571. doi: 10.1155/2022/6304571

Table 3.

Dialysis adequacy and prescription parameters in placebo patients (n = 86).

Day spKt/V Urea removal rate (%) Dialysate flow (mL/min) Dialysate potassium concentration (mmol/L) Prescribed ultrafiltration rate (mL) Blood flow (mL/min)
−7 1.71 (0.38) 74.3 (5.8) 548.0 (131.1) 2.24 (0.46) 2785.8 (1228.1) 321.0 (95.8)
1 1.99 (0.85) 73.3 (6.4) 545.3 (133.7) 2.23 (0.48) 2753.0 (1197.1) 316.0 (95.8)
3 2.24 (0.48)
5 2.23 (0.48)
8 2.22 (0.47)
12 2.22 (0.47)
15 2.24 (0.48)
22 2.26 (0.57)
29 1.67 (0.35) 72.3 (7.1) 545.9 (143.3) 2.21 (0.47) 2807.6 (1176.5) 317.3 (95.0)
36 2.22 (0.47)
43 2.22 (0.48)
50 2.22 (0.48)
57 1.70 (0.43) 73.6 (5.4) 548.7 (130.4) 2.24 (0.46) 2843.0 (1098.3) 320.7 (98.8)

Data are mean (standard deviation). Data are shown for the 86 placebo patients with predialysis sK+ measurements at randomization (visit 4, day 1). sK+, serum potassium; spKt/V, target single pool Kt/V.